AIM ImmunoTech Inc. (AIM) stock
AIMNYSEBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$0.13−0.01 (-3.75%)
Close on Nov 18, 2026Market cap $3.98MP/E –Yield –
AIM ImmunoTech gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
AIM ImmunoTech's gross profit for the twelve months ending Sep 30, 2015 was -$1.41M. For fiscal 2014 it was -$1.05M. The highest annual figure on record is -$473.00K in fiscal 2009.
Annual gross profit
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2014 | Dec 31, 2014 | -$1.05M | – |
| FY2013 | Dec 31, 2013 | -$1.08M | – |
| FY2012 | Dec 31, 2012 | -$1.78M | – |
| FY2011 | Dec 31, 2011 | -$882.00K | – |
| FY2010 | Dec 31, 2010 | -$1.21M | – |
| FY2009 | Dec 31, 2009 | -$473.00K | – |
See a number that looks wrong?